| Factor Information | |
|---|---|
| Data ID | 1721 |
| Factor | plasma-acylated ghrelin levels |
| Description | Plasma-acylated ghrelin, ET-1, and NO levels were significantly elevated in PH- CHD group compared with the CHD group. |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | Plasma-acylated ghrelin, ET-1, and NO levels were significantly elevated in PH- CHD group compared with the CHD group. |
| p Value | <0.001 |
| Conclusion | Plasma-acylated ghrelin, ET-1, and NO levels were significantly elevated in PH-CHD group compared with the CHD group. Acylated ghrelin may be a new biomarker of PH-CHD. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 548 |
| CHD Type | isolated CHD |
| CHD Subtype | VSD/ASD/PDA/other |
| Reference | |
|---|---|
| PMID | 25981561 |
| Year | 2015 |
| Title | Plasma Levels of Acylated Ghrelin in Children with Pulmonary Hypertension Associated with Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | blood | |
| Region | Luzhou, China | |
| Method | N/A | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | right heart catheterization | |
| Group | CHD-PAH children(Treatment) | CHD chlidren(Control) |
| Number | N/A | N/A |
| Age | 35.9 ± 20.9 months | N/A |
| Gender (Male: Female) | 13:7 | N/A |
| Marker Level | 86.8±21.7ng/ ml | 27.4±9.5ng/ml |
